Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 1997

Conditions

Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorKidney CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesNeuroblastomaOvarian CancerTesticular Germ Cell Tumor

Interventions

BIOLOGICAL

recombinant interleukin-12

Trial Locations (1)

46202-5265

Indiana University Cancer Center, Indianapolis

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Indiana University School of Medicine

OTHER

NCT00003107 - Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors | Biotech Hunter | Biotech Hunter